6.
Keri R, Chand K, Budagumpi S, Somappa S, Patil S, Nagaraja B
. An overview of benzo[b]thiophene-based medicinal chemistry. Eur J Med Chem. 2017; 138:1002-1033.
DOI: 10.1016/j.ejmech.2017.07.038.
View
7.
Higazy S, Samir N, El-Khouly A, Giovannuzzi S, Begines P, Gaber H
. Identification of thienopyrimidine derivatives tethered with sulfonamide and other moieties as carbonic anhydrase inhibitors: Design, synthesis and anti-proliferative activity. Bioorg Chem. 2024; 144:107089.
DOI: 10.1016/j.bioorg.2023.107089.
View
8.
Khatri C, Indalkar K, Patil C, Goyal S, Chaturbhuj G
. Novel 2-phenyl-4,5,6,7-tetrahydro[b]benzothiophene analogues as selective COX-2 inhibitors: Design, synthesis, anti-inflammatory evaluation, and molecular docking studies. Bioorg Med Chem Lett. 2017; 27(8):1721-1726.
DOI: 10.1016/j.bmcl.2017.02.076.
View
9.
Sroor F, Aboelenin M, Mahrous K, Mahmoud K, Elwahy A, Abdelhamid I
. Novel 2-cyanoacrylamido-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as potent anticancer agents. Arch Pharm (Weinheim). 2020; 353(10):e2000069.
DOI: 10.1002/ardp.202000069.
View
10.
El-Helw E, Alzahrani A, Ramadan S
. Synthesis and antimicrobial activity of thiophene-based heterocycles derived from thiophene-2-carbohydrazide. Future Med Chem. 2024; 16(5):439-451.
DOI: 10.4155/fmc-2023-0304.
View
11.
Elrayess R, Abdel Aziz Y, Elgawish M, Elewa M, Yassen A, Elhady S
. Discovery of Potent Dual EGFR/HER2 Inhibitors Based on Thiophene Scaffold Targeting H1299 Lung Cancer Cell Line. Pharmaceuticals (Basel). 2020; 14(1).
PMC: 7823583.
DOI: 10.3390/ph14010009.
View
12.
Lipinski C
. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2014; 1(4):337-41.
DOI: 10.1016/j.ddtec.2004.11.007.
View
13.
Daina A, Michielin O, Zoete V
. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017; 7:42717.
PMC: 5335600.
DOI: 10.1038/srep42717.
View
14.
Li W, Yin Y, Shuai W, Xu F, Yao H, Liu J
. Discovery of novel quinazolines as potential anti-tubulin agents occupying three zones of colchicine domain. Bioorg Chem. 2018; 83:380-390.
DOI: 10.1016/j.bioorg.2018.10.027.
View
15.
Ramadan S, Haleem D, Abd-Rabboh H, Gad N, Abou-Elmagd W, Haneen D
. Synthesis, SAR studies, and insecticidal activities of certain N-heterocycles derived from 3-((2-chloroquinolin-3-yl)methylene)-5-phenylfuran-2(3)-one against L. larvae. RSC Adv. 2022; 12(22):13628-13638.
PMC: 9069532.
DOI: 10.1039/d2ra02388a.
View
16.
El-Sewedy A, El-Bordany E, Mahmoud N, Ali K, Ramadan S
. One-pot synthesis, computational chemical study, molecular docking, biological study, and in silico prediction ADME/pharmacokinetics properties of 5-substituted 1H-tetrazole derivatives. Sci Rep. 2023; 13(1):17869.
PMC: 10587066.
DOI: 10.1038/s41598-023-44615-4.
View
17.
Kamal S, Derbala H, Alterary S, Ben Bacha A, Alonazi M, El-Ashrey M
. Synthesis, Biological, and Molecular Docking Studies on 4,5,6,7-Tetrahydrobenzo[]thiophene Derivatives and Their Nanoparticles Targeting Colorectal Cancer. ACS Omega. 2021; 6(43):28992-29008.
PMC: 8567357.
DOI: 10.1021/acsomega.1c04063.
View
18.
Herbst R, Khuri F
. Mode of action of docetaxel - a basis for combination with novel anticancer agents. Cancer Treat Rev. 2003; 29(5):407-15.
DOI: 10.1016/s0305-7372(03)00097-5.
View
19.
Miura K, Oohashi T, Matsuda S, Igarashi Y
. [CHEMICAL AND CHEMOTHERAPEUTICAL STUDIES ON THE FURAN DERIVATIVES. XXX. SYNTHESES AND ANTIBACTERIAL ACTIVITIES OF 2-(5-NITRO- 2-FURYL)VINYL HETEROCYCLICS]. Yakugaku Zasshi. 1963; 83:771-7.
DOI: 10.1248/yakushi1947.83.8_771.
View
20.
Mohamed M, Attia Y, Shouman S, Abdelhamid I
. Anticancer Activities of New N-hetaryl-2-cyanoacetamide Derivatives Incorporating 4,5,6,7-Tetrahydrobenzo[b]thiophene Moiety. Anticancer Agents Med Chem. 2017; 17(8):1084-1092.
DOI: 10.2174/1871520617666170110154110.
View